FY2025 · period end Dec '25 · from the 10-K filed Feb 11, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $48.19B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001140361-26-020036 | May 5, 2026 | May 8, 2026 | May 8, 2026 20:10 UTC | EDGAR |
| 8-K | 0000014272-26-000008 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 11:01 UTC | EDGAR |
| 10-Q | 0000014272-26-000010 | Mar 31, 2026 | Apr 30, 2026 | Apr 30, 2026 15:44 UTC | EDGAR |
| 10-K | 0000014272-26-000004 | Dec 31, 2025 | Feb 11, 2026 | Feb 11, 2026 16:35 UTC | EDGAR |
| 8-K | 0000014272-26-000002 | Feb 5, 2026 | Feb 5, 2026 | Feb 5, 2026 12:07 UTC | EDGAR |
| 8-K | 0001140361-26-000929 | Jan 12, 2026 | Jan 12, 2026 | Jan 12, 2026 15:20 UTC | EDGAR |
| 8-K | 0001140361-25-042607 | Nov 17, 2025 | Nov 18, 2025 | Nov 18, 2025 21:41 UTC | EDGAR |
| 8-K | 0001140361-25-041380 | Oct 31, 2025 | Nov 10, 2025 | Nov 10, 2025 21:06 UTC | EDGAR |
Direct links to SEC EDGAR. BMY has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Cash Provided by (Used in) Operating Activities·Q2 2016
Major restatementwas$25M
Revised up in a 10-Q. Any P/OCF built on the original was 88.2% too high.
Net Cash Provided by (Used in) Operating Activities·Q1 2016
Major restatementwas-$386M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·FY 2018
Major restatementwas$5.9B
Revised up in a 10-K. Any P/OCF built on the original was 15.9% too high.
Net Cash Provided by (Used in) Operating Activities·FY 2015
Major restatementwas$1.8B
Revised up in a 10-K. Any P/OCF built on the original was 13.0% too high.
Net Cash Provided by (Used in) Operating Activities·Q3 2016
Major restatementwas$1.4B
Revised up in a 10-Q. Any P/OCF built on the original was 12.0% too high.
Revenue, Net (Deprecated 2018-01-31)·Q2 2009
Major restatementwas$5.4B
Revised down in a 10-K. Any P/S built on the original was 15.4% too low.
BMY is not the only one.
See every restatement we've found across the market — or get an alert the next time BMY revises a number.
Restatements are detected by comparing every vintage of a fact across all of BRISTOL MYERS SQUIBB CO's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows BMY's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling BRISTOL MYERS SQUIBB CO — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on BMY yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on BMY and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $45.01B |
| $46.16B |
| $46.38B |
| Gross Profit | $34.26B | $34.33B | $34.31B | $36.02B | $36.45B |
|---|
| Operating Income | — | — | — | — | — |
|---|
| Net Income | $7.05B | negative: -$8.95B | $8.03B | $6.33B | $6.99B |
|---|
| EPS (Diluted) | $3.46 | negative: -$4.41 | $3.86 | $2.95 | $3.12 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $90.04B | $92.60B | $95.16B | $96.82B | $109.31B |
| Total Liabilities | $71.53B | $76.22B | $65.67B | $65.70B | $73.31B |
| Stockholders' Equity | $18.51B | $16.39B | $29.48B | $31.12B | $36.01B |
| Cash & Equivalents | $10.21B | $10.35B | $11.52B | $9.32B | $14.32B |
| Total Debt | — | — | $4.50B | $6.00B | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $14.16B | $15.19B | $13.86B | $13.07B | $16.21B |
| Capital Expenditures | $1.31B | $1.25B | $1.21B | $1.12B | $0.97B |
| Free Cash Flow | $12.85B | $13.94B | $12.65B | $11.95B | $15.23B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 71.1% | 71.1% | 76.2% | 78.0% | 78.6% |
| Operating Margin | 0.3% | negative: -0.1% | 0.1% | 0.2% | 0.2% |
| Net Margin | 0.1% | negative: -0.2% | 0.2% | 0.1% | 0.2% |
| Return on Equity | 40.4% | negative: -39.0% | 26.5% | 18.9% | 18.9% |
| Return on Assets | 7.7% | negative: -9.5% | 8.4% | 6.1% | 6.1% |
| Debt / Equity | 2.65× | 3.25× | 0.15× | 0.19× | 1.50× |
